Efeito inibitório in vitro de drogas antituberculose, antifúngicas e análogos químicos da isoniazida frente a Histoplasma capsulatum var. capsulatum

• Ano de defesa: 2009
• Autor(a) principal: Marques, Francisca Jakelyne de Farias
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Palavras-chave em Português: Testes de Sensibilidade Microbiana; Histoplasma; Isoniazida; Antimicóticos
• Link de acesso: http://www.repositorio.ufc.br/handle/riufc/1892

In the past years, the improvement of mycological diagnosis methods and immunosuppressive diseases have caused a great impact in the incidence of opportunistic and deep mycoses all around the world, which motivated the performance of new antifungal drugs prospective studies. Histoplasmosis is a systemic mycosis caused by the fungus Histoplasma capsulatum var. capsulatum, which may mimic tuberculosis, in healthy individuals, concerning clinical and radiological aspects.ome cases of histoplasmosis that are refractory to the treatment with conventional antifungal drugs have been described. The aim of this study was to determine the in vitro inhibitory effect of the antituberculosis drugs: isoniazid (INH), pyrazinamide (PZA) and ethambutol (EMB); antifungal drugs: amphotericin B (AMB), fluconazole (FLC), itraconazole (ITC) and voriconazole (VRZ) and chemical analogs of isoniazid against strains of H. capsulatum (n=30), as well as to evaluate the use of different culture media for the performance of the susceptibility tests. For such, first, the antituberculosis agents INH, PZA and EMB and the analogs of isoniazid were tested isolatedely, and then, in association with the antifungal drugs FLC, ITC and VRZ, against 18 strains of H. capsulatum, previously grown onto BHI agar, through broth macrodilution technique. Each of the 12 remaining strains grown onto potato agar, BHI agar, 2% malt extract agar and lactritmel agar were microscopically analyzed, concerning the presence of tuberculate macroconidia, which were quantified as follows: 0-10, 10-50 and >50 macroconidia/field. Fungal cultures were used to determine the susceptibility of H. capsulatum to the antifungal agents AMB, FLC, ITC and VRZ, through broth microdilution methodology. The antituberculosis drugs inhibited the in vitro growth of the fungal strains, with MICs ranging from 0.04 to 0.30 mg/mL for INH; 0.55 to 3.13 mg/mL for PZA and 1.56 to 6.25 mg/mL for EMB. Concerning antifungal drugs, all the strains were susceptible, with MIC values ranging from 0.0625 to 0.25 µg/mL for AMB; 15.62 to 62.5 µg/mL for FLC; 0.0039 to 0.0312 µg/mL for ITC, and 0.00156 to 0.25 µg/mL for VRZ. When associating antituberculosis drugs with azole derivatives, all associations inhibited the in vitro growth of H. capsulatum strains, and synergy was observed for the nine combinations tested. Analogs of isoniazide presented MICs of 2, 4, 8 and 15-fold better than the standard antituberculosis drug. Basing on micromorphological analysis, the lowest quantification of macroconidia/field (0-10) was observed for 11, 10, 6 and 7 strains previously grown onto potato agar, BHI agar, malt agar and lactritmel agar, respectively. Malt agar was the most adequate medium for the production of macroconidia, 10-50 and >50/field, with a total of six strains; followed by lactritmel agar, with 5 strains. Concerning the relationship between MIC and culture medium used during the test, it was observed that inoculum from strains grown onto malt agar and BHI agar allowed the detection of the MIC for 11 strains. On the other hand, for those inocula grown onto potato agar and lactritmel agar, the MIC values were not detected for 8 and 5 strains, respectively. The results of this study provide additional data on the antifungal potential of antituberculosis drugs and their interactions with azole derivatives. However, new studies are necessary in order to determine the mechanism of action of these compounds on fungal cellular metabolism.